Article | October 27, 2021

Steps to Consider For Implementing Continuous Bioprocessing

By Marc Bisschops, Senior Director, SLS - Integrated Process Solutions, Pall

Drug development iStock-1067499066

Now that continuous manufacturing is well established in small molecule circles, conversations have turned to continuous bioprocessing and bioprocess intensification. But some manufacturers are resistant to change. Here, Marc Bisschops, Senior Director, SLS - Integrated Process Solutions at Pall, explains why companies should be considering continuous for faster, more efficient routes to market.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: